Pillstats
Rx only · Injection, Solution, Concentrate · Intramuscular

Epinephrine

Epinephrine

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3992
US makers9 labelers
Packages11
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1452914365822025 Q12025 Q22025 Q32025 Q42026 Q1
347
Rx · 2026 Q1
1.2K
Units dispensed
+921%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Baxter Healthcare Corporationunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
BPI Labs LLCunknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown1SUPPLYING
Civica, Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
ProPharma Distributionunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 14, 2026
    RECALLRecall (Class III): Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-69…

    Failed Impurities/Degradations Specifications — Recalling firm: Fresenius Kabi USA, LLC — US Nationwide.